The high prevalence of C. trachomatis worldwide has underscored the importance of identifying specific immunogenic antigens in facilitating diagnosis as well as vaccine development The aim of this study is to evaluate IncA antibody and antigen production in natural human infections. Our temporal expression study showed that IncA transcription and protein expression could be detected as early as 4 hours after the start of infection. Antibody responses could be detected in urine and genital swab samples from C. trachomatis-positive patients. It is especially interesting to note that the IncA antigen could be detected in urine. In conclusion, we have identified IncA as an important antigen in human. The potential applicability of the IncA antibody or antigen in the diagnosis as well as to vaccine development for C. trachomatis is also discussed.
Adderley-KellyB.StephensE.M., 2005. Chlamydia: A major health threat to adolescents and young adults. ABNF. J.16:52.
2.
PeipertJ.F.2003. Clinical practice. Genital chlamydial infections. N. Engl. J. Med.349:2424.
3.
BrunhamR.C.Rey-LadinoJ., 2005. Immunology of Chlamydia infection: Implications for a Chlamydia trachomatis vaccine. Nat. Rev. Immunol.5:149.
4.
FieldsK.A.HackstadtT., 2002. The chlamydial inclusion: Escape from the endocytic pathway. Annu. Rev. Cell Dev. Biol.18:221.
5.
KawaD.E.SchachterJ.StephensR.S., 2004. Immune response to the Chlamydia trachomatis outer membrane protein PorB. Vaccine22:4282.
6.
KuboA.StephensR.S., 2000. Characterization and functional analysis of PorB, a Chlamydia porin and neutralizing target. Mol. Microbiol.38:772.
7.
BasS.MuzzinP.VischerT.L., 2001. Chlamydia trachomatis serology: Diagnostic value of outer membrane protein 2 compared with that of other antigens. J. Clin. Microbiol.39:4082.
8.
BasS.MuzzinP.NinetB.BornandJ.E.ScieuxC.VischerT.L., 2001. Chlamydial serology: Comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens. J. Clin. Microbiol.39:1368.
9.
FlingS.P.SutherlandR.A.SteeleL.N.HessB.D'OrazioS.E.MaisonneuveJ.LampeM.F.ProbstP.StarnbachM.N., 2001. CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proc. Natl. Acad. Sci. U.S.A.98:1160.
10.
StarnbachM.N.LoomisW.P.OvendaleP.ReganD.HessB.AldersonM.R.FlingS.P., 2003. An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+ T cell response. J. Immunol.171:4742.
11.
RockeyD.D.ScidmoreM.A.BannantineJ.P.BrownW.J., 2002. Proteins in the chlamydial inclusion membrane. Microbes Infect. 4:333.
12.
HackstadtT.Scidmore-CarlsonM.A.ShawE.I.FischerE.R., 1999. The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell Microbiol. 1:119.
13.
GeislerW.M.SuchlandR.J.RockeyD.D.StammW.E., 2001. Epidemiology and clinical manifestations of unique Chlamydia trachomatis isolates that occupy nonfusogenic inclusions. J. Infect. Dis.184:879.
14.
BellandR.J.ZhongG.CraneD.D.HoganD.SturdevantD.SharmaJ.BeattyW.L.CaldwellH.D., 2003. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. U.S.A.100:8478.
15.
BannantineJ.P.StammW.E.SuchlandR.J.RockeyD.D., 1998. Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates. Infect. Immun.66:6017.
16.
BannantineJ.P.GriffithsR.S.ViratyosinW.BrownW.J.RockeyD.D., 2000. A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell Microbiol. 2:35.
17.
HsuM.C.TsaiP.Y.ChenK.T.LiL.H.ChiangC.C.TsaiJ.J.KeL.Y.ChenH.Y.LiS.Y., 2006. Genotyping of Chlamydia trachomatis from clinical specimens in Taiwan. J. Med. Microbiol55:301.
18.
SuchlandR.J.RockeyD.D.BannantineJ.P.StammW.E., 2000. Isolates of Chlamydia trachomatis that occupy non-fusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect. Immun.68:360
19.
BetsouF.SueurJ.M.OrfilaJ., 1999. Serological investigation of Chlamydia trachomatis heat shock protein 10. Infect. Immun.67:5243.
20.
SubtilA.Dautry-VarsatA., 2004. Chlamydia: Five years A.G. (after genome). Curr. Opin. Microbiol.7:85.
21.
RojasA.NavarroM.D.FornesF.E.SerraE.SimarroE.RojasJ.RuizJ., 2005. Value of serological testing for diagnosis of legionellosis in outbreak patients. J. Clin. Microbiol.43:4022.
22.
UrnovitzH.B.SturgeJ.C.GottfriedT.D.MurphyW.H., 1999. Urine antibody tests: New insights into the dynamics of HIV-1 infection. Clin. Chem.45:1602.
23.
YamamotoS.UemuraN.OkamotoS.YamaguchiS.MashibaH.TachikawaT., 2000. A new rapid test for detecting anti-Helicobacter pylori antibody excreted into urine. Helicobacter. 5:160.
24.
ZhuC.TianH.LuL.LiY.FengZ.MaL.GuanX., 2000. A study on producing monoclonal antibody with one diagnostic marker screened electrophoretically from the urine of individuals infected with Schistosoma japonicum. Diagn. Microbiol. Infect. Dis.38:237.
25.
YzermanE.P.den BoerJ.W.LettingaK.D.SchellekensJ.DankertJ.PeetersM., 2002. Sensitivity of three urinary antigen tests associated with clinical severity in a large outbreak of Legionnaires' disease in The Netherlands. J. Clin. Microbiol.40:3232.
26.
NeumanM.I.HarperM.B., 2003. Evaluation of a rapid urine antigen assay for the detection of invasive pneumococcal disease in children. Pediatrics112:1279.
27.
KlempnerM.S.SchmidC.H.HuL.SteereA.C.JohnsonG.McCloudB.NoringR.WeinsteinA., 2001. Intralaboratory reliability of serologic and urine testing for Lyme disease. Am. J. Med.110:217.
